Premium
Viscoelastic testing in benign hematologic disorders: Clinical perspectives and future implications of point‐of‐care testing to assess hemostatic competence
Author(s) -
Speybroeck Jacob,
Marsee Mathew,
Shariff Faadil,
Zackariya Nuha,
Grisoli Anne,
Lune Stefani Vande,
Larson Emilee E.,
Hatch Jordan,
McCauley Ross,
Shariff Faisal,
Aversa John G.,
Son Michael,
Agostini Vanessa,
Campello Elena,
Simioni Paolo,
Scărlătescu Escaterina,
Kwaan Hau,
Hartmann Jan,
Fries Dietmar,
Walsh Mark
Publication year - 2020
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1111/trf.16088
Subject(s) - hematologic disorders , medicine , intensive care medicine , point of care testing , hematologic disease , disease , pathology
Viscoelastic tests (VETs) have been used routinely for liver transplantation, cardiac surgery, and trauma, but only recently have found clinical utility in benign hematologic disorders. Therefore, guidelines for diagnosis and treatment of these disorders based on viscoelastic variables have been adapted from the existing transplant, cardiothoracic surgery, and trauma resuscitation literature. As a result, diagnostic and therapeutic strategies for benign hematologic disorders utilizing VETs are not uniform. Accordingly, even though there has been a recent increase in the utilization of VET for the diagnosis and treatment of such disorders, the literature is still in its early stages. Analysis of point‐of‐care viscoelastic tracings from benign hematologic disorders has the potential to allow prompt recognition of disease and to guide patient‐specific intervention. Here we present a review describing the application of VETs to benign hematologic disorders.